CD19 and acute lymphoblastic leukemia: Here, we report our clinical observations of the impact of prior blinatumomab treatment on the outcome of subsequent CD19 CAR-T cell therapy in seven pediatric patients with r/r BCP-ALL treated at Wroclaw Medical University between January 2021 and March 2022.